EYEN
Closed
Eyenovia Inc
10.56
+0.18 (+1.73%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 10.38
Day's Range: 9.8201 - 11.205
Send
sign up or login to leave a comment!
When Written:
3.53
Eyenovia Inc is a clinical-stage ophthalmic company that is focused on developing and commercializing therapeutics for treating a wide range of eye diseases and conditions. The company's lead product candidate, MicroPine, is a topical treatment for myopia, which is currently in Phase III clinical trials. Eyenovia also has other product candidates in its pipeline, including MicroStat, which is a treatment for mydriasis (pupil dilation) during ophthalmic procedures, and MicroTears, which is a treatment for dry eye disease. The company is headquartered in New York and was founded in 2014.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








